Bronchial asthma and cardiovascular comorbidity: interconnections and approaches to therapy
- Authors: Starodubtseva I.A1, Lesina V.S1,2, Kostina N.E2, Venderevskaya K.V2
-
Affiliations:
- N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia
- Voronezh Regional Clinical Hospital No. 1
- Issue: Vol 8, No 5 (2022)
- Pages: 62-66
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/289092
- DOI: https://doi.org/10.18565/therapy.2022.5.62-66
- ID: 289092
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
I. A Starodubtseva
N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia
Email: starodubtsevairina10gmail.com
394036, Voronezh, 10 Studencheskaya Str
V. S Lesina
N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia; Voronezh Regional Clinical Hospital No. 1394066, Voronezh, 151 Moskovsky Avenue
N. E Kostina
Voronezh Regional Clinical Hospital No. 1
Email: nata166k0yahoo.com
394066, Voronezh, 151 Moskovsky Avenue
K. V Venderevskaya
Voronezh Regional Clinical Hospital No. 1394066, Voronezh, 151 Moskovsky Avenue
References
- Reddel H.K., Bacharier L.B., Bateman E.D. et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key 65 changes. Eur Respir J. 2021; 59(1): 2102730. https://dx.doi.org/10.1183/13993003.02730-2021.
- Zinellu E., Piras B., Ruzittu G. et al. Recent advances in inflammation and treatment of small airways in asthma.Int J Mol Sci. 2019;20(11): 2617. https://dx.doi.org/10.3390/ijms20112617.
- Hamid Q, Tulic' M.K., Liu M.C., Moqbel R. Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol. 2003; 111(1 Suppl): S5-S12; discussion S12-17. https://dx.doi.org/10.1067/mai.2003.22.
- Bogos K., Ostoros G. COPD. Koranyi Bulletin. 2019. URL: https://szakmai.koranyi.hu/bulletin (date of access - 12.02.2021).
- Weatherburn C.J., Guthrie B., Mercer S.W., Morales D.R.Comorbidities in adults with asthma: population-based cross-sectional analysis of 1.4 million adults in Scotland. Clin Exp Allergy. 2017; 47(10): 1246-52. https://dx.doi.org/10.1111/cea.12971.
- Kaplan A., Szefler S.J., Halpin D.M.G. Impact of comorbid conditions on asthmatic adults and children. NPJ Prim Care Respir Med. 2020;30(1): 36. https://dx.doi.org/10.1038/s41533-020-00194-9.
- Boulet L.-P. Influence of comorbid conditions on asthma. EurRespir J. 2009; 33(4): 897-906. https://dx.doi.org/10.1183/09031936.00121308.
- Boulet L.-P., Boulay M.-E. Asthma-related comorbidities. Expert Rev Respir Med. 2011; 5(3): 377-93. https://dx.doi.org/10.1586/ers.11.34.
- Ledford D.K., Lockey R.F. Asthma and comorbidities. Curr Opin Allergy Clin Immunol. 2013; 13(1): 78-86. https://dx.doi.org/10.1097/ACI.0b013e32835c16b6.
- Авдеев С.Н., Ненашева Н.М., Жуденков К.В. с соавт. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации. Пульмонология. 2018; 3: 341-358. @@ Avdeev S.N., Nenasheva N.M., Zhudenkov K.V. et al. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya = Pulmonology. 2018; 3: 341-358 (In Russ.). https://dx.doi.org/10.18093/0869-0189-2018-28-3-341-358. EDN: XWCRRZ.
- Ненашева Н.М. Омализумаб в терапии тяжелой бронхиальной астмы. Эффективная фармакотерапия. 2014; 29: 24-35. @@ Nenasheva N.M. Omalizumab in therapy of severe bronchial asthma. Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2014;29: 24-35 (In Russ.)]. EDN: SXVCNH.
- Федеральные рекомендации по диагностике и лечению бронхиальной астмы. Российское респираторное общество. 2016.Доступ: http://spulmo.ru/obshchestvo/news/news-812/ (дата обращения - 15.06.2022). @@Federal guidelines for the diagnosis and treatment of bronchial asthma.Russian Respiratory Society. 2016. URL: http://spulmo.ru/obshchestvo/news/news-812/ (date of access - 15.06.2022) (In Russ.).
- Гринберг Н.Б., Воронина Л.П., Полунина О.С. с соавт. Функциональное состояние сосудистого эндотелия и его влияние на ремоделирование миокарда у больных бронхиальной астмой. Астраханский медицинский журнал. 2012; 2: 58-61. @@Grinberg N.B., Voronina L.P., Polunina O.S. et al. The functional status of vascular endothelium and its influence on remodeling of myocardium of patients with bronchial asthma. Astrakhanskiy meditsinskiy zhurnal = Astrakhan Medical Journal. 2012; 2: 58-61 (In Russ.)
- Schanen J.G., Iribarren C., Schanen J.G. et al. Asthma and incident cardiovascular disease: The atherosclerosis risk in communities study. Thorax. 2005; 60(8): 633-38. https://dx.doi.org/10.1136/thx.2004.026484.
- Ненашева Н.М. Биологическая терапия бронхиальной астмы: настоящее и будущее. Consilium Medicum. 2016; 11: 30-38. @@Nenasheva N.M. Biological therapy of asthma: present and future. Consilium Medicum. 2016; 11: 30-38 (In Russ.)]
- Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; 6: 87-93. @@Arkhipov V.V., Grigoryeva E.V., Gavrishina E.V. Control of bronchial asthma in Russia: results of NIKA multi-center observational study. Pulmonologiya = Pulmonology. 2011; 6: 87-93 (In Russ.)]. https://dx.doi.org/10.18093/0869-0189-2011-0-6-87-93.
- Grow from Knowledge (GFK). Изучение поведения врачей при лечении пациентов с бронхиальной астмой (БА) и хронической обструктивной болезнью легких (ХОБЛ). 2018. Доступ: https://www.gfk.com/fileadmin/user_upload/dyna_content/RU/Documents/News/2015/0ut-patient-treatment-ofbronchial-asthma-current-clinical-practice-review.doc (дата обращения - 26.06.18). @@The study of the behavior of doctors in the treatment of patients with bronchial asthma and COPD. 2018. URL: https://www.gfk.com/fileadmin/user_upload/dyna_content/RU/Documents/News/2015/0ut-patient-treatment-ofbronchial-asthma-current-clinical-practice-review. doc (date of access - 26.06.18) (In Russ.)
- Харитонс М.А., Рамазанова К.А. Современные представления о лечении бронхиальной астмы. Терра Медика Нова. 2001; 1: 22-24. @@Kharitons M.A., Ramazanova K.A. Modern ideas about the treatment of bronchial asthma. Terra Medica Nova. 2001; 1: 22-24 (In Russ.).
- Сергеева Г.Р., Емельянов А.В., Коровина О.В. с соавт. Тяжелая бронхиальная астма: характеристика пациентов в клинической практике. Терапевтический архив. 2015; 12: 26-31. @@Sergeeva G.R., Emelyanov A.V., Korovina O.V. et al. Severe asthma: characteristics of patients in clinical practice. Terapevticheskiy arkhiv = Therapeutic Archive. 2015; 12: 26-31 (In Russ.)]. https://dx.doi.org/10.17116/terarkh2015871226-31
- Рудакова А.В. Фармакоэкономические аспекты поддерживающей терапии бронхиальной астмы ингаляционными кортикостероидами. Качественная клиническая практика. 2013; 1: 47-49. @@Rudakova A.V. Pharmacoeconomic aspects of maintenance therapy of bronchial asthma with inhaled corticosteroids. Kachestvennaya klinicheskaya praktika = Good Clinical Practice. 2013; 1: 47-49(In Russ.)]
- Gorecka D. Cardiac arrhythmias in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 1997; 52(3): 278-81.
- Sbarbaro G., Parentini G.C., Angelinelli P.L. et al. [Respiratory insufficiency and cardiac arrhythmia: the rationale of treatment. Minerva Med. 1993; 84(6): 307-12 (in Italian)].
- Takemura M., Matsumoto H., Niimi A. et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006; 27(5): 908-12. https://dx.doi.org/10.1183/09031936.06.00114405.
- Yokoyama A., Kohno N., Fujino S. et al. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med. 1995; 151(5): 1354-58. https://dx.doi.org/10.1164/ajrccm.151.5.7735584.
- Aviles R.J., Martin D.O., Apperson-Hansen C. et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003; 108(24): 3006-10. https://dx.doi.org/10.1161/01.CIR.0000103131.70301.4F.
- Schnabel R.B., Larson M.G., Yamamoto J.F. et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010; 121(2): 200-7. https://dx.doi.org/10.1161/CIRCULATI0NAHA.109.882241.
- Adimadhyam S., Schumock G.T., Walton S. et al. Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: A nested case-control study. Pharmacotherapy. 2014; 34(4): 315-23. https://dx.doi.org/10.1002/phar.1336.
- Sears M.R. Adverse effects of beta-agonists. J Allergy Clin Immunol. 2002; 110(6 Suppl): S322-28. https://dx.doi.org10.1067/mai.2002.129966.
- Cazzola M., Matera M.G., Donner C.F. Inhaled B2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs. 2005; 65(12): 1595-610. https://dx.doi.org/10.2165/00003495-200565120-00001.
- Robin E.D., McCauley R. Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists. Chest. 1992; 101(6): 1699702. https://dx.doi.org/10.1378/chest.101.6.1699.
- Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004: 125(6): 2309-21. https://dx.doi.org/10.1378/chest.125.6.2309.
- Mohammad H.A., Abdulfttah M.T., Abdulazez A.O. et al. A study of electrolyte disturbances in patients with chronic stable asthma and with asthma attacks. Egypt J Chest Dis Tuberc. 2014; 63(3): 529-34.
- Cazzola M., Rogliani P., Calzetta L., Matera M.G. Bronchodilators in subjects with asthma-related comorbidities. Respir Med. 2019; 151: 43-48. https://dx.doi.org/10.1016/j.rmed.2019.04.001.
- Crane J., Burgess C.D., Graham A.N., Maling T.J. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. N Z Med J. 1987; 100(824): 309-11.
- Maak C.A., Tabas J.A., McClintock D.E. Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure? J Emerg Med. 2011; 40(2): 135-45. https://dx.doi.org/10.1016/j.jemermed.2007.11.056.
- Gulsen A. Asthma phenotypes and current biological treatments. In book: Asthma [Working Title]. April 2021. }https://dx.doi.org/10.5772/intechopen.97376.
Supplementary files
![](/img/style/loading.gif)